Primary Article

Double-Blind Study of Guanabenz Acetate in Hypertensive Patients

Authors: RAYMOND F. GRENFELL MD

Abstract

ABSTACTTwenty-five patients with essential hypertension were given 50 mg of hydrochlorothiazide twice daily. Patients were randomly assigned to one of two treatment groups. The group given 6 mg of guanabenz twice daily as well as hydrochlorothiazide showed a significant decrease in systolic blood pressure in the supine, sitting, and standing positions at months 1, 2, and 3, while the diastolic blood pressure was significantly reduced in all three positions at months 1, 2, 3, and 4. In the group given placebo and hydrochlorothiazide, the mean systolic and diastolic blood pressures were significantly reduced in the standing and sitting positions at month 1 and in the standing, sitting, and supine positions at month 4. When mean systolic and diastolic blood pressures of the two groups were compared, the group treated with guanabenz and hydrochlorothiazide had significantly lower systolic and diastolic blood pressure readings in all three positions at month 2 and significantly lower standing diastolic blood pressure readings at month 3 than did the group treated with placebo and hydrochlorothiazide.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References